DCLK1 has been identified as an understudied druggable kinase whose overexpression is linked to multiple human cancers such as colorectal and gastric cancer as well as pancreatic ductal carcinoma. This evidence concerns the gene DCLK1 and pancreatic ductal adenocarcinoma.